Yan-Nan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yan-Nan Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chao Song
Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People's Republic of China
1 shared publication - Chen-Chen Wang
Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou 221002, People’s Republic of China
1 shared publication - Li-Ping Chen
Department of Pain, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
1 shared publication - Wen Shen
Jiangsu Province Key Laboratory of Anesthesiology and Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, Jiangsu 221002, People’s Republic of China
1 shared publication - Xue-Ming Hu
Department of Pain Medicine, The Affiliated Hospital of Xuzhou Medical College, 99 Huaihai West Road, Xuzhou 221002, People's Republic of China.
1 shared publication - Yuan Han
Department of Anesthesiology, Eye & ENT Hospital of Fudan University, Shanghai
1 shared publication
Latest Publications
- Open Access
- 16 April 2014
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 11 (1) , 75
CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord
Previous studies have demonstrated that chemokine CXCL12 and its receptor CXCR4 are critical for pain sensitization, but the mechanisms involved are not clear. In this study, we investigated the specific cellular mechanisms of CXCL12/CXCR4 chemokine signaling in the development and maintenance of bone cancer pain after tumor cell implantation (TCI).
- 16 April 2014
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 11 (1) , 75
Open AccessCXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord
Previous studies have demonstrated that chemokine CXCL12 and its receptor CXCR4 are critical for pain sensitization, but the mechanisms involved are not clear. In this study, we investigated the specific cellular mechanisms of CXCL12/CXCR4 chemokine signaling in the development and maintenance of bone cancer pain after tumor cell implantation (TCI).